Powered by ZigaForm version

Application for Clinical Trials

Product Details

Title of Study: Assessing Response to neo-adjuvant Taxotere and Trastuzumab in Nigerian women with HER2-positive breast cancer

Subtitle: ARTETTA

Protocol; Version: CABC123D4567; 1

Phase of Study: Phase 3;

Study Type: industry sponsor

Approval Date:

Applicant Name: Prof. (Mrs) Peace Babalola

Address: Pharmacy Department, University College Hospital Ibadan

Date of Application: 2019-07-17

Applicant Name: Prof. (Mrs) Peace Babalola

Sponsor: University of Chicago, Bilogical Science Division/University of Chicago Medical Center

Address of Sponsor: University of Chicago Center for Global Health (UC CGH), 60637 Chicago, USA

Trial Sites: 1. Lagos State University Teaching Hospital, Ikeja, Lagos State 2. Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) Ile Ife 3. Lagos University Teaching Hospital LUTH 4. University College Hospital, Ibadan

Product Type: Drug

Status of Approval: on-going

Was this post helpful?